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Abstract
Malnutrit ion is associated with poor outcomes in 
critically ill patients. Although nutritional support is yet 
to be proven to improve mortality in non-malnourished 
critically ill patients, early enteral feeding is considered 
best practice. However, enteral feeding is often limited 
by delayed gastric emptying. The best method to 
clinically identify delayed gastric emptying and feed 
intolerance is unclear. Gastric residual volume (GRV) 
measured at the bedside is widely used as a surrogate 
marker for gastric emptying, but the value of GRV 
measurement has recently been disputed. While the 
mechanisms underlying delayed gastric emptying require 
further investigation, recent research has given a better 
appreciation of the pathophysiology. A number of 
pharmacological strategies are available to improve the 
success of feeding. Recent data suggest a combination 
of intravenous metoclopramide and erythromycin to be 
the most successful treatment, but novel drug therapies 
should be explored. Simpler methods to access the 
duodenum and more distal small bowel for feed delivery 
are also under investigation. This review summarises 
current understanding of the factors responsible for, and 
mechanisms underlying feed intolerance in critical illness, 
together with the evidence for current practices. Areas 
requiring further research are also highlighted.
© 2007 WJG. All rights reserved.
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INTRODUCTION
Malnutrition in general ward patients is associated with 
a prolonged length of  stay[1], and increased infective 
complications[2,3]. Evidence that nutritional support 
of  critically ill patients results in improved outcome 
is, however, limited. Descriptive studies indicate that 
underfeeding in the critically ill may be associated with 
an inability to wean from mechanical ventilation[4] and 
an increase in complications, particularly infections[5]. It 
is not clear whether these effects are causal or relate to 
an inability to achieve nutritional goals in patients with 
increased illness severity. However, severe underfeeding 
(less than 25% of  requirements), increases the risk of  
nosocomial blood stream infections independent of  illness 
severity[6]. In addition, the implementation of  an algorithm 
to improve nutritional delivery in intensive care showed 
that this approach not only improved the provision of  
nutrition, but was also associated with a decreased hospital 
length of  stay and a trend to decreased hospital mortality[7]. 
Despite the lack of  unequivocal benefit on mortality, 
nutritional support is an accepted standard of  care.
All of  the feeding approaches used in the critically 
ill are associated with potential complications. Enteral 
nutrition, usually via a nasogastric tube, may lead to 
gastro-oesophageal reflux, with both overt and micro 
pulmonary aspiration, which potentially increases the risk 
of  nosocomial pneumonia[8,9]. Total parenteral nutrition 
(TPN) on the other hand is associated with complications 
due to the insertion and presence of  a central line, sepsis, 
increased cost and possible bacterial translocation across 
an atrophic gut mucosa. While TPN readily provides full 
nutritional support, enteral nutrition is less successful and 
only 50% of  patients’ nutritional goals are met using the 
enteral route of  nutrient delivery[6,10-12]. Inability to achieve 
an enteral feeding target is commonly due to cessation 
of  feeds, with the decision to stop mostly due to delayed 
gastric emptying. In clinical practice this diagnosis is 
based on large gastric residual volumes (GRV)[11], despite 
a paucity of  evidence to support this decision making 
process. The accuracy of  GRV estimation and its use in 
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feeding protocols is contentious (see below). Nonetheless 
enteral nutrition is currently considered to be superior 
to TPN, and early successful enteral nutrition to be best 
clinical practice[13]. Improving the success of  nasogastric 
administration of  nutrient requires an understanding of  
the gastrointestinal disturbances that underlie slow gastric 
emptying and developing strategies to treat these.
Current knowledge of  these dysfunctions is incomplete, 
but recent studies have gone some way towards clarifying 
the mechanisms responsible for impaired nutrient delivery. 
UPPER GASTROINTESTINAL MOTILITY IN 
HEALTH
Appreciation of  the pathophysiology observed in 
critical illness requires an understanding of  normal 
gastric and small intestinal motility. In health, the rate 
of  gastric emptying is regulated via an integration of  
motor activity[14,15]. These motor patterns are determined 
by a mixture of  neural and humoral mechanisms 
which modulate intrinsic myogenic activity. Regular 
depolarisation, which varies in frequency according to 
the region of  the gut, is initiated by “pacemaker” activity 
from a network of  cells embedded in the GI tract called 
interstitial cells of  Cahal. Whether or not electrical activity 
initiates mechanical contraction, and the amplitude of  
such contractions, is determined by the influence of  
neural and humoral factors[16]. Extrinsic neural infl uence is 
largely mediated by the vagus, with parasympathetic effects 
causing an increase in motility. Sympathetic innervation 
from the prevertebral ganglia is inhibitory. A large number 
of  hormones including cholecystokinin (CCK), peptide 
YY (PYY), motilin, glucagon like peptide-1 (GLP-1) and 
ghrelin are involved in regulation of  this gut motility.
The motor activity of  the gut differs between the 
fasting and fed state. Fasting motility is divided into 
three phases which migrate along the upper gut (the 
migratory motor complex); phaseⅠis characterised by 
quiescence, phase Ⅱ by irregular contractile activity and 
phase Ⅲ by periods of  regular contractions sometimes 
referred to as the activity front[17]. Propulsion of  luminal 
contents occurs mainly during late phase Ⅱ or phase 
Ⅲ, minimising stagnation of  contents and subsequent 
bacterial proliferation. The precise regulation of  MMC 
activity is unclear, but phase Ⅲ activity can be triggered by 
stimulation of  motilin receptors.
Ingestion of  nutrients results in a postprandial pattern 
of  activity. The proximal stomach acts as a reservoir 
(and provides a pressure gradient to control delivery of  
nutrient to the distal stomach) with the fundus relaxing 
in response to small intestinal nutrient. Subsequently, the 
fundus undergoes slow sustained contractions, which may 
act to distribute contents distally and is believed to have 
a major role in the control of  liquid emptying[18,19]. Post-
prandial activity in the distal stomach is characterised by 
irregular contractions which aid mixing and propagation 
of  nutrient along the gastrointestinal tract. Mixing is due 
to intermittent isolated antral waves contracting against 
a closed pylorus. Gastric emptying of  nutrient occurs 
predominantly in a pulsatile fashion when peristaltic 
wave activity continues through an open pylorus, aiding 
movement of  contents into the duodenum[19,20]. The 
peristaltic wave is dependent on the integration of  motor 
activity in the proximal and distal stomach, as well as the 
proximal small intestine[14,21,22].
The distal stomach and proximal small intestine 
behave as a functional unit and regulate gastric emptying 
of  solids and liquids. This antro-pyloro-duodenal region 
is characterised by patterns of  motility. These patterns 
include intermittent isolated pressure waves which vary 
in frequency and amplitude and coordinated propagated 
(peristaltic) pressure waves which migrate for variable 
distances through the antrum, across the pylorus and into 
the duodenum[23]. Transpyloric flow occurs as a result 
of  both peristaltic and non-peristaltic antro-duodenal 
gradients[20,23]. The rate of  transpyloric flow is regulated 
by feedback from receptors in the small intestine[24], where 
nutrient triggers neurohumoral responses resulting in 
reduced antral waves and increased isolated pyloric motor 
activity. In addition to the variation in isolated waves there 
is a reduction in antegrade propagating pressure waves[25-27]. 
This results in decreased transpyloric movement of  
nutrient and limits its delivery into the small intestine to 
2-3 kcal/min[14,28,29].
UPPER GASTROINTESTINAL MOTOR
DYSFUNCTION IN CRITICAL ILLNESS
Delayed gastric emptying is common in the Intensive Care 
Unit, occurring in approximately 50% of  mechanically 
ventilated critically ill patients[30-35]. In these patients both 
fasting and fed motility of  the upper GI tract are frequently 
impaired[36,37]. There is a virtual absence of  gastric phase 
Ⅲ motility during the fasting state, although the frequency 
of  phase Ⅲ activity in the duodenum appears normal[38] 
perhaps reflecting a loss of  integration within the antro-
pyloro-duodenal unit. During feeding, however, a number 
of  additional abnormalities become apparent. These include 
delayed fundal relaxation, prolonged recovery[39], reduced 
antral motility[36,38] and increased isolated pyloric activity 
(Figure 1). These occur when the small intestine is exposed 

















Figure 1  Manometric tracing from healthy and critically ill subjects during 
duodenal feeding (1 kcal/min). Location of pressure sensors is shown on left. In 
the healthy subjects antral and duodenal peristalsis is seen, whilst the increase in 
activity in the pylorus in the critically ill is associated with absent antral activity[36].
www.wjgnet.com
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delayed gastric emptying[36]. Thus delayed gastric emptying 
may reflect hypersensitivity to small intestinal nutrient. In 
contrast to delayed fundal relaxation and impaired antral 
motility, duodenal activity usually persists[36,37] (although the 
organisation of  duodenal activity is frequently abnormal)[40] 
and may explain why, in the absence of  prokinetics, post 
pyloric feeding may potentially be more successful than 
gastric enteral nutrition.
The mechanisms underlying motor dysfunction in critical 
illness are uncertain. However, concentrations of  CCK and 
PYY, which normally increase when nutrient reaches the 
small intestine in health, are markedly increased in critical 
illness especially in those intolerant of  enteral feeding[41,42]. It 
is, therefore, possible that CCK and PYY may mediate the 
enhanced entero-gastric refl ex described above.
Infl ammatory cells in the intestinal wall contribute to 
motility disturbances after surgery. Surgical manipulation 
of  the small intestine activates macrophages to release 
cytokines and cause an additional leukocyte response in 
the muscularis externa[43]. In murine models this has been 
suggested to contribute to delayed gastric emptying[44]. 
However, while infl ammation from a local insult has been 
shown to cause altered motility in the post-operative 
setting, the impact of  inflammation from systemic non-
operative insults is unknown. The effect of  infl ammation 
on motility in critical illness warrants further investigation.
RISK FACTORS FOR FEED INTOLERANCE
The aetiology of  upper gastrointestinal motor dysfunction 
in critical illness is unclear, but is probably multifactorial. 
Potential factors implicated include the admission diagnosis, 
pre-existing illnesses, electrolyte abnormalities (such as 
hyperglycaemia), age, gender, drugs (such as narcotics or 
catecholamines), recent abdominal surgery, shock, and 
circulating cytokines[45]. Illness severity, quantified as an 
APACHE Ⅱ score (calculated using age, physiological 
variables and chronic health conditions) also correlates with 
delayed gastric emptying[46]. 
Admission diagnosis
Gastric emptying data suggest that there are high risk groups 
for feed intolerance. These include patients with burns[32,33], 
head injuries[34], sepsis and multi-trauma[46]. However, 
patients with burns who are fed early and aggressively have 
a low incidence of  feed intolerance[47] implying that earlier 
feeding is protective.
Premorbid conditions
Patients with premorbid disordered glucose metabolism 
are frequently admitted to the ICU[48] and delayed gastric 
emptying occurs commonly with diseases such as diabetes 
mellitus. However, critically ill patients with pre-existing 
type 2 diabetes appear to have normal or even rapid 
gastric emptying of  liquid nutrient compared to non-
diabetics[49]. Faster emptying in diabetics may initially 
appear counter intuitive, but in non-critically ill diabetic 
patients, gastric emptying of  liquid nutrient is also quicker 
when compared to volunteers without diabetes[50-52]. This 
is in direct contrast with the delay in gastric emptying 
of  solid or semi-solid meals, in diabetics. As previously 
mentioned the proximal stomach contributes to normal 
gastric emptying. Critically ill patients without diabetes 
have impairment of  proximal gastric relaxation leading 
to delayed emptying. However, in the critically ill patient 
with pre morbid type 2 diabetes, the proximal stomach 
relaxes, distends and accommodates a larger volume during 
infusion of  duodenal nutrition, which is a response that 
mirrors what occurs in normal healthy physiology[53,54]. In 
addition, critically ill diabetic patients have preservation 
of  fundal waves while the non diabetic critically patients 
have decreased frequency of  isolated waves in the fundus. 
Fundal waves may aid progression of  nutrient in critical 
illness[53]. The exact mechanism causing this “pseudo 
normalization” of  gastric motility and gastric emptying is 
unknown, but may be related to autonomic neuropathy 
in the diabetic patient, potentially causing a loss of  the 
enhanced enteric feedback process that is common to 
critical illness.
Increasing age has been associated with a slowing of  
gastric emptying in healthy volunteers[55,56]. As ICU patients 
are, in general, older than the non-hospitalised population, 
it would be anticipated that age might contribute to the 
delay in gastric emptying seen in critical illness. Elderly 
critically ill patients are at increased risk of  delayed 
emptying compared to younger patients[33,46]. Gender has 
also been reported to impact on gastric emptying in health, 
with women having slower emptying rates compared to 
men[57-59], although this association, unlike age, does not 
seem to apply in the critically ill[33].
Electrolyte abnormalities
Hyperglycaemia occurs frequently in cr i t ical ly i l l 
patients, even in patients with normal baseline glucose 
homeostasis [48]. In health, hyperglycaemia impairs 
gastrointestinal motility and gastric emptying[60], so it 
follows that the critically ill also have an association 
between hyperglycaemia and delayed gastric emptying, with 
a subsequent effect on feed intolerance[61]. As discussed 
previously, eugylcaemic diabetic patients do not have an 
increased incidence of  delayed gastric emptying and feed 
intolerance.
Drugs
Many drugs used in the critically ill can potentially 
influence gastrointestinal motility. Of  particular concern 
are sedatives, analgesics and vasopressor agents. Both 
endogenous and administered opiates, acting via mu 
receptors, may disrupt upper gastrointestinal motility[62-66]. 
The impact of  opiates, on the gastrointestinal tract, is due 
to both central effects and peripheral opioid receptors 
located in the gut. Low dose epidural morphine delays 
gastric emptying[67] and causes disordered motility[66] 
implying a central effect is important. The effect of  
receptor agonism is additive when both spinal and 
parenteral morphine are administered together[65]. Opiates 
slow gastric emptying as a result of  decreased gastric 
tone[64] and antral contractions[68] with retrograde duodenal 
activity[66]. Although opiates have been associated with 
delayed gastric emptying in the critically ill[33], similar 
www.wjgnet.com
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abnormalities have also been observed in critically ill 
patients not receiving exogenous narcotics[36]. Using 
propofol as a sedative in the critically ill is considered by 
clinicians to cause less slowing of  gastrointestinal function. 
This belief  is based on studies in healthy people; where 
low doses of  propofol appear to have limited effects on 
gastric emptying in healthy humans[69,70] and because using 
propofol in combination with morphine attenuates the 
decrease in gastric tone usually seen when the opiate is 
used as a single agent. However, the evidence is far from 
conclusive. While propofol improved gastric tone during 
morphine administration, it had no effect on actual gastric 
emptying[64] and in animal models propofol prolonged 
phase 1 motility during fasting in pigs[71]. The effects of  
propofol on gastrointestinal motor function may be dose 
related as the drug, at anaesthetic doses, reduces gastric 
emptying and increases intestinal transit time in mice[72]. 
In humans it remains difficult to accurately compare 
sedative agents in critically ill patients, as intensivists have 
usually avoided a propofol based sedative regime in the 
more acutely ill population because of  concerns with 
hypotension and the likelihood of  prolonged sedative use. 
No prospective comparison of  propofol and morphine, 
adjusted for illness severity, has confirmed superiority 
of  propofol on gastric emptying. In addition, propofol 
has been associated with feed intolerance in head injured 
patients[73] and it may be prudent to avoid a dogmatic 
belief  in the benefits of  propofol for feeding tolerance. 
Midazolam, a benzodiazepine often prescribed with an 
opiate as a combination sedative in the ICU, also reduces 
gastric emptying and prolongs gastrointestinal transit[72].
High concentrations of  circulating catecholamines, 
either endogenous or exogenous, are common in critically 
ill patients. Adrenaline reduces gastric emptying by a beta-
adrenergic effect[65]. This is likely to be a class effect, as 
low dose dopamine compared to placebo adversely affects 
gastroduodenal motility in the critically ill[66]. In addition, 
high dose catecholamines have been associated with a 
reduction in the prokinetic effect of  erythromycin[45].
IDENTIFICATION OF FEED INTOLERANCE
& DELAYED GASTRIC EMPTYING
Gastric emptying is rarely directly measured in the critically 
ill other than for research purposes. Regular measurement 
of  gastric residual volume (GRV) during the infusion 
of  enteral nutrition has been considered a convenient 
clinical tool by many clinicians and is used as a surrogate 
to indicate gastric emptying, success of  feeding and 
potential risk of  aspiration. Despite acceptance of  GRV 
in feeding protocols by the majority of  ICUs, the utility 
and significance of  this measurement is controversial as 
it is dependent on a number of  factors. These include the 
position of  the tube, tube characteristics (such as tube 
type and number of  openings), the volume of  syringe 
used[74] and the operator performing the test[75]. GRV is 
usually performed every 4-6 h and, unlike the continuous 
monitoring of  other end organ function, the signifi cance 
of  a ‘snap shot’ or a one off  value may be hard to 
interpret. In addition, the relationship between GRV and 
gastric emptying is weak[32,35,74]. These factors have lead 
to a lack of  consensus on an acceptable value for GRV 
during enteral feeding. Computer simulated modelling 
suggests that GRV should plateau between 232 and 464 
ml during enteral feeding at a rate of  25-125 mL/h[76]. 
Currently the majority of  intensive care units have 
protocols for feeding that consider a change in delivery 
rate or site if  the GRV is between 150-400 mL/s. The 
evidence for this is limited, as 25% of  patients with a GRV 
> 150 mL have normal gastric emptying and can continue 
to be fed successfully without prokinetics[77]. In addition, 
and of  more importance clinically, is that the high rate of  
aspiration and oesophageal regurgitation observed in these 
patients is independent of  GRV[78]. As the current clinical 
signifi cance of  GRV is uncertain a convenient, continuous 
and more reliable test of  gastric emptying would assist in 
the nutritional management of  these patients. 
TREATMENT OPTIONS
Failure of  delivery of  nasogastric nutrition is usually 
managed either by pharmacological intervention or 
a change in the route of  delivery of  feeding. Various 
prokinetic agents are available but few, to date, have been 
studied in depth in critically ill patients.
PHARMACOTHERAPY
Metoclopramide
Metoclopramide is a dopamine receptor antagonist with 
central and peripheral effects, as well as weak 5-HT3 
receptor antagonism and 5-HT4 agonism[79]. The drug 
releases acetylcholine from gut neurones, antagonising 
the inhibitory effect of  dopamine on gastrointestinal 
motility. Jooste et al demonstrated that metoclopramide 
improved gastric emptying[80] in critically ill patients. 
However, recent data[81,82] have shown that in critically 
ill patients rapid tachyphylaxis occurs, such that at 7 d, 
only 25% of  pat ients g iven metoclopramide wi l l 
continue to be fed successfully. The recommended dose 
of  metoclopramide is 10 mg TDS or QID as there is 
limited evidence of  improved effi cacy at higher doses in 
the critically ill. Without supporting evidence it remains 
prudent to limit the dose administered in the non-research 
setting because of  the neurological side effect profi le of  
the drug. Metoclopramide is ineffective as a prokinetic in 
head injured patients[73] and potentially has a deleterious 
effect in patients at risk of  raised intracranial pressure[72]. 
As such other agents are preferred in patients who have 
suffered a signifi cant neurological insult.
Erythromycin
The macrolide antibiotic, erythromycin, when administered 
in sub-antibiotic doses (70-250 mg), acts as a motilin 
agonist and stimulates gastric motility. Motilin receptors 
are found in abundance in the gastric antrum and proximal 
duodenum and induce contractions in the gastrointestinal 
tract. Intravenous erythromycin increases antral motility 
and accelerates gastric emptying in unselected critically 
ill patients[83] and reduces GRV in critically ill patients 
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with feed intolerance[84]. Erythromycin is a more effective 
prokinetic than metoclopramide in this patient group[81,82]. 
However, as with metoclopramide, its efficacy decreases 
over time so that after 7 d of  treatment only about 45% 
of  patients remain tolerant to nasogastric feeding. The 
combination of  erythromycin and metoclopramide is 
superior to either drug alone with less tachyphylaxis 
(Figure 2). Using a combination of  the two drugs, 70% of  
patients can be successfully fed by nasogastric tube at 6 d[82]. 
Enthusiasm for the use of  erythromycin is tempered by 
fears of  cardiac toxicity and bacterial resistance. Clinicians 
should remain vigilant to drug interactions in critically 
ill patients, as patients may be on multiple drugs (such 
as amiodarone and haloperidol) that predispose to a 
prolonged QT interval. It is likely that cardiac toxicity 
is minimised by using low dose therapy. A recent report 
by Ritz et al demonstrated 70 mg erythromycin IV to be 
as effective as 200 mg in improving gastric emptying in 
the critically ill[85]. Currently intravenous erythromycin 
is available in 500 mg ampoules and it may be easier to 
administer 100 mg rather than 70 mg at the bedside. The 
optimal timing between doses has not been clarifi ed but 
is probably between BD and QID. Bacterial resistance 
remains a concern, regardless of  dosing schedule, and 
investigation of  motilin agonists without antibiotic effect 
or other unrelated agents is warranted.
Opiate receptor antagonists
As opiate administration may be an important cause of  
reduced gastrointestinal motility and unsuccessful feeding 
in the critically ill, opiate antagonists are logical options for 
treatment. To avoid antagonism of  required analgesic and 
sedating properties naloxone has been administered via a 
nasogastric tube. Eight mg naloxone administered every 6 h, 
via nasogastric tube, reduced GRV in 84 mechanically 
ventilated patients who were receiving Ⅳ fentanyl. The 
treatment group also had a lower incidence of  ventilator 
associated pneumonia (VAP)[86]. However, the decreased 
incidence of  VAP in the naloxone group did not lead to a 
reduction in time to wean from mechanical ventilation, or 
time to discharge from ICU and the effi cacy of  naloxone 
requires confi rmation. As naloxone is packaged in 400 μg 
ampoules, a dose of  8 mg involves the inconvenience 
of  opening 20 ampoules 4 times a day. This restricts 
easy administration and increases expense, which may 
have limited the uptake of  this approach. There has 
also been research into other mu receptor blockers, 
such as Alvimopan, a peripherial mu-opioid receptor 
antagonist. Importantly, unlike naloxone this agent does 
not antagonise opioid analgesia[87]. Alvimopan reverses 
the inhibitory effect of  opiate on small bowel motility as 
measured by scintigraphy[88] and has been used successfully 
in postoperative patients to shorten both the time to bowel 
recovery and time to discharge from hospital[89]. However, 
it has not been formally assessed in critically ill patients. 
CCK receptor antagonists
Elevated CCK levels inhibit gastric emptying and motility in 
health[90] and are associated with feed intolerance in critically 
ill patients (Figure 3)[41]. CCK1 receptor antagonists have 
been reported to improve lower oesophageal sphincter 
function and accelerate gastric emptying. This class of  drug 
therefore has potential as an effective treatment for delayed 
gastric emptying and feed intolerance in the critically ill but 
this has not been examined.
5-HT4 receptor agonists
Serotonin (5-Hydroxytryptamine), a monoamine neu-
rotransmitter, acts on a variety of  receptor types in the 
gastrointestinal tract with the effect of  serotonin depend-






















































Figure 2  Kaplan Meier plots comparing the effects of erythromycin (200 mg IV 
BD) and metoclopramide (10 mg IV QID) in the treatment of feed intolerance. 
Signifi cant tolerance developed to both drugs over 7 d. The combination of both 
drugs is effective rescue therapy[81].
Deane A et al . Feed intolerance in critical illness                                                                                               3913
www.wjgnet.com
Figure 3  Plasma CCK concentrations during fasting and duodenal nutrient 
stimulation in both feed tolerant and intolerant critically ill patients. Plasma levels 
of CCK for feed tolerant patients match those seen in healthy subjects receiving 
intra duodenal nutrition. Feed intolerant patients have higher levels whilst fasting 
































stimulates peristalsis there had been interest in the use of  
these drugs as prokinetic agents, following their successful 
use in irritable bowel syndrome[92]. Tegaserod, a serotonin 
partial agonist, had been reported to increase gastric motility 
in critically ill patients[93]. However, in March 2007 the FDA 
requested Tegaserod be withdrawn due to an increase in 
cardiovascular side effects. The mechanism of  this unclear, 
but reminds critical care clinicians to remain cautious 
when prescribing recently introduced drugs for off  licence 
indications.
Ghrelin
Ghrelin is a natural ligand for the growth hormone (GH) 
receptor[94] and has strong GH releasing activity. A motilin 
related peptide, ghrelin has a number of  other actions 
including stimulation of  appetite (hence the label of  the 
“fattening” peptide[95]), gastrokinetic effects and positive 
inotropic effect on the circulation[96]. The motility effects 
include induction of  gastric phase Ⅲ contractions as well 
as increasing the resting tone of  the proximal stomach[94]. 
Ghrelin has been successfully used as a prokinetic in 
diabetic gastroparesis[97]. Treatment with an agent that has 
anabolic effects, improves gastrointestinal motility as well 
as providing circulatory support has inherent desirable 
properties. However, there are no data as yet on the use of  
ghrelin in the critically ill, and enthusiasm for exogenous 
administration of  the peptide is tempered by previous 
studies where the use of  GH in the critically ill was 
associated with increased mortality[98].
NON PHARMACOLOGICAL APPROACHES
Post pyloric feeding tubes 
In patients with delayed gastric emptying successful 
feeding may be achieved with post pyloric feeding tubes[99]. 
Systematic reviews, however, have failed to demonstrate 
an impact of  this practice on nutritional delivery or clinical 
outcomes after early initiation of  post pyloric feeding[100,101]. 
Furthermore, in patients who fail nasogastric feeding, 
post pyloric tubes and prokinetic therapy are equally 
effective[102]. Thus current recommendations are that post 
pyloric feeding should be reserved for patients who fail 
nasogastric feeding and do not respond to prokinetics.
Enthusiasm for post pyloric nutrition is moderated 
by the lack of  an accepted technique to place the feeding 
tubes. Ideally, the technique would be easy to learn, 
have a high success rate, incur minimal cost and require 
only portable equipment so that the patient need not be 
transported out of  the unit. Passing feeding tubes into 
the duodenum is difficult in the critically ill and rapid 
placement usually requires fluoroscopic or endoscopic 
support. Access to either technique is limited in many 
Intensive Care Units. Insertion of  post pyloric feeding 
tubes, without endoscopy or radiological imaging, has been 
reported using various proprietary tubes and techniques. 
In general such devices either rely on self-migration or 
magnetic guidance. The Tiger TubeTM (Cook Medical) has 
small plastic tabs which allow the tube to be captured by 
peristalsis and carried distally. Anecdotal reports suggest 
it is faster than blind placement by the bedside. A large 
multi-centre study is currently recruiting in Australia that 
will compare nutrient delivery with a post pyloric Tiger 
Tube against standard nasogastric feeding. However, 
concerns have been expressed about the potential for peri-
procedure bleeding and there has been published reports 
of  mucosal damage[103]. It would seem prudent to be 
cautious about long term placement, as well as insertion 
or removal of  the tube if  a coagulopathy is present. The 
GabrielTM feeding tube (Syncro Medical Innovations) uses 
a magnet to guide the tip of  the tube through the pylorus. 
Another electromagnetic device is the CorTrakTM (Viasys 
Medisystems) which relies upon an electromagnetic fi eld 
transmitted from the catheter tip measured by a receiver 
placed unit on the patient. This signal is transferred to a 
graphic display to guide and confirm placement. These 
two techniques appear safe, and are easy to use, with high 
success rates of  tubes rapidly entering the duodenum[104-106]. 
An alternative approach uses erythromycin, air insuffl ation 
and stomach ECG[107]. This has achieved post pyloric 
placement success rates (up to 90%) that are equivalent 
to the proprietary tube approaches. This approach is 
more economical than proprietary tubes, endoscopy or 
fl uoroscopy. 
CONCLUSION 
Provision of  adequate nutrition in critical illness is generally 
accepted as desirable and early feeding is considered 
superior to delayed feeding. The enteral route is preferred 
as it is cheaper, and may be associated with less sepsis; 
however, the high incidence of  gastric and small intestinal 
dysmotility slows gastric emptying and often limits 
nasogastric delivery of  nutrients. Although in widespread 
use, gastric residual volumes are an unreliable measure 
of  gastric emptying, may underestimate tolerance to 
nasogastric feeding and do not predict complications such 
as regurgitation and aspiration. Delayed gastric emptying 
probably results from disturbances in the frequency and 
organisation of  contractions in both the proximal and 
distal stomach. Increased neuro-hormonal feedback in 
response to relatively small amounts of  nutrient in the 
small intestine, possibly mediated by CCK may contribute 
to this motor dysfunction. Awareness of  patients at risk 
for delayed gastric emptying and pre emptive management 
may decrease the incidence of  feed intolerance amongst 
critically ill patients. The current best treatment of  patients 
who fail nasogastric feeding is prokinetic therapy. A 
combination of  erythromycin and metoclopramide may 
reduce the common problem of  tachyphylaxis. The dose 
of  erythromycin to promote motility may be smaller than 
previously appreciated and could alleviate some concerns 
relating to adverse side effects. If  prokinetics fail, delivery 
of  post pyloric nutrition should be considered. Changes 
in nutritional management in the future may include 
better means to identify patients at risk of  delayed gastric 
emptying, accepting higher gastric residual volumes, and 
the use of  nutrients designed to optimise gastric emptying. 
Novel agents, including antagonists to CCK or opiates, 
as well as agonists of  grehlin or motilin, need further 
investigation.
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